FDA — authorised 12 November 1964
- Application: ANDA060570
- Marketing authorisation holder: APOTHECON
- Local brand name: FUNGIZONE
- Indication: LOTION — TOPICAL
- Status: approved
🇺🇸 ABLC in United States
FDA authorised ABLC on 12 November 1964
Marketing authorisations
FDA — authorised 1 March 1966
- Application: ANDA060517
- Marketing authorisation holder: APOTHECON
- Local brand name: FUNGIZONE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Status: approved
ABLC in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is ABLC approved in United States?
Yes. FDA authorised it on 12 November 1964; FDA authorised it on 1 March 1966; FDA has authorised it.
Who is the marketing authorisation holder for ABLC in United States?
APOTHECON holds the US marketing authorisation.